Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kelly J. Fleetwood"'
Autor:
Stine H. Scheuer, Kelly J. Fleetwood, Kirsty A.M. Licence, Stewart W. Mercer, Daniel J. Smith, Cathie L.M. Sudlow, Gregers S. Andersen, Sarah H. Wild, Caroline A. Jackson
Publikováno v:
Scheuer, S H, Fleetwood, K J, Am Licence, K, Mercer, S W, Smith, D J, Lm Sudlow, C, Andersen, G S, Wild, S H & Jackson, C A 2022, ' Severe mental illness and quality of care for type 2 diabetes : a retrospective population-based cohort study ', Diabetes Research and Clinical Practice, vol. 190, no. 110026, 110026, pp. 110026 . https://doi.org/10.1016/j.diabres.2022.110026
AIMS: To compare quality of care for type 2 diabetes in people with severe mental illness (SMI) versus no mental illness.METHODS: We used routinely collected linked data to create a retrospective cohort study. We included 158,901 people diagnosed wit
Publikováno v:
BioScience. 66:983-989
Autor:
Kelly J. Fleetwood, Francis Bursa, Karie J. Hirst, Ronggai Sun, Ann Yellowlees, Peter C. Fusco, Susan Charlton
Publikováno v:
BioScience. 66:63-72
Outliers within a bioassay are not uncommon, especially with animal models. Ordinary linear regression is sensitive to outliers; even a single outlier may compromise parallelism and other assay suitability criteria, skew the estimate of relative pote
Publikováno v:
PDA Journal of Pharmaceutical Science and Technology. 69:248-263
Relative potency bioassays are used to estimate the potency of a test biological product relative to a standard or reference product. It is established practice to assess the parallelism of the dose–response curves of the products prior to calculat
Autor:
Thomas R. Fuerst, Peter C. Fusco, Ashok Ganesan, Jeremy H. Lakey, Karie J. Hirst, Allan Watkinson, Chris S. LeButt, Kelly J. Fleetwood, Andrei Soliakov
Publikováno v:
Clinical and Vaccine Immunology. 20:1659-1668
Aluminum salts are the most widely used vaccine adjuvants, and phosphate is known to modulate antigen-adjuvant interactions. Here we report an unexpected role for phosphate buffer in an anthrax vaccine (SparVax) containing recombinant protective anti
Publikováno v:
BioScience. 63:490-498
Two approaches to the estimation of relative potency for dose—time—response assays are compared: the application of a generalized linear model to the dichotomized responses and survival analysis of the time to response. Survival analysis is widel